Guest Editorial: Warning Letters ? A Symptom?

Kuwahara,Steven;

Publication

Article

March 15, 2002

BioPharm International

BioPharm International-03-15-2002

Volume15

Issue 3

Guest Editorial: Warning Letters ? A Symptom?

Author(s):

Steven S. Kuwahara

by Steven S. Kuwahara, Titan Pharmaceuticals Numerous warning letters and consent decrees have revealed problems in coping with even simple parts of the GMPs.

To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

Inside Washington: Biotech Manufacturing ? Obstacle or Opportunity?

Guest Editorial: Warning Letters ? A Symptom?

The Importance of Freezing on Lyophilization Cycle Development

Outsourcing Outlook: Using Earned-Value Analysis for Better Project Management

Business Benefits of Computer Systems Validation

Validation of Quantitative PCR Assays?Addressing Virus Contamination Concerns

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!